Clinical Trial Update: Fondaparinux in Critically Ill Patients With Renal Failure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating fondaparinux in critically ill patients with renal failure. The study assessed venous thromboembolism outcomes and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: Wayne State University | Conditions: Venous Thromboembolism | Phase 4 | Status: COMPLETED | Results posted: 2015-06-19